Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.

Anticancer research - 1 Apr 2017

Wróbel Tomasz, Butrym Aleksandra, Łacina Piotr, Rybka Justyna, Gębura Katarzyna, Mazur Grzegorz, Bogunia-Kubik Katarzyna

Abstract excerpt

BACKGROUND/AIM: Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) play an important role in the initiation of angiogenesis. We aimed to assess whether polymorphisms within the genes coding for these angiogenic activators (VEGF (rs3025039;C>T) and bFGF (rs308395;G>C)) contribute to susceptibility and/or progression in multiple myeloma patients (MM) and to chemotherapy. PATIENTS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Disease Progression
Share to Fibroblast Growth Factor 2
Share to Follow-Up Studies
Share to Multiple Myeloma
Share to Neoplasm Staging
Share to Polymorphism, Restriction Fragment Length
Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 28373444
DOI: 10.21873/anticanres.11514

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.PMID 28373444Read ↗

Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.Semantic proximity Read ↗

Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.Semantic proximity Read ↗

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.Semantic proximity Read ↗

VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.Semantic proximity Read ↗

MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.Semantic proximity Read ↗

Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.Semantic proximity Read ↗

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.Semantic proximity Read ↗

Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesisSemantic proximity Read ↗

Genetic variations in multiple myeloma II: association with effect of treatment.Semantic proximity Read ↗

A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma.Semantic proximity Read ↗

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.Semantic proximity Read ↗

Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.